BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36571487)

  • 1. Pancreatic K
    Soret B; Hense J; Lüdtke S; Thale I; Schwab A; Düfer M
    Biol Chem; 2023 Mar; 404(4):339-353. PubMed ID: 36571487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
    Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K
    Pang ZD; Wang Y; Wang XJ; She G; Ma XZ; Song Z; Zhao LM; Wang HF; Lai BC; Gou W; Du XJ; Deng XL
    FASEB J; 2019 Dec; 33(12):14760-14771. PubMed ID: 31690106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K
    Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
    Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting K
    Todesca LM; Maskri S; Brömmel K; Thale I; Wünsch B; Koch O; Schwab A
    Cell Physiol Biochem; 2021 May; 55(S3):131-144. PubMed ID: 34043300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ion channels in control of pancreatic stellate cell migration.
    Storck H; Hild B; Schimmelpfennig S; Sargin S; Nielsen N; Zaccagnino A; Budde T; Novak I; Kalthoff H; Schwab A
    Oncotarget; 2017 Jan; 8(1):769-784. PubMed ID: 27903970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tale of two pancreases: exocrine pathology and endocrine dysfunction.
    Rickels MR; Norris AW; Hull RL
    Diabetologia; 2020 Oct; 63(10):2030-2039. PubMed ID: 32894313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines.
    Kovalenko I; Glasauer A; Schöckel L; Sauter DR; Ehrmann A; Sohler F; Hägebarth A; Novak I; Christian S
    PLoS One; 2016; 11(8):e0160658. PubMed ID: 27494181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible New Strategies for the Treatment of Congenital Hyperinsulinism.
    Sikimic J; Hoffmeister T; Gresch A; Kaiser J; Barthlen W; Wolke C; Wieland I; Lendeckel U; Krippeit-Drews P; Düfer M; Drews G
    Front Endocrinol (Lausanne); 2020; 11():545638. PubMed ID: 33193079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islets and pancreatic ductal adenocarcinoma - An opportunity for translational research from the 'Bench to the Bedside'.
    Barreto SG; Michael MZ; Keating DJ
    Pancreatology; 2020 Apr; 20(3):385-390. PubMed ID: 32057682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Langerhans islets in pancreatic ductal adenocarcinoma.
    Pour PM
    Front Biosci; 1997 Jun; 2():d271-82. PubMed ID: 9206985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TADG-12 as an early marker in the development of pancreatic ductal adenocarcinoma (PDAC): involvement of insulin containing cells.
    Amsterdam A; Raanan C; Shpigner L; Shwiqi A; Melzer E; Schreiber L
    Acta Histochem; 2014 Jun; 116(5):781-7. PubMed ID: 24560937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of c-kit expression in pancreatic adenocarcinoma: a novel stem cell marker responsible for the progression of the disease.
    Amsterdam A; Raanan C; Polin N; Melzer E; Givol D; Schreiber L
    Acta Histochem; 2014 Jan; 116(1):197-203. PubMed ID: 23978330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo.
    Bachmann M; Rossa A; Varanita T; Fioretti B; Biasutto L; Milenkovic S; Checchetto V; Peruzzo R; Ahmad SA; Patel SH; Lukowski R; Edwards MJ; Ceccarelli M; Gulbins E; Zoratti M; Mattarei A; Szabo I
    Cell Death Dis; 2022 Dec; 13(12):1055. PubMed ID: 36539400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic acinar-specific overexpression of Reg2 gene offered no protection against either experimental diabetes or pancreatitis in mice.
    Li B; Wang X; Liu JL
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G413-21. PubMed ID: 20489047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of human pancreatic islet large conductance Ca(2+)-activated K+ channel (hSlo) cDNAs: evidence for high levels of expression in pancreatic islets and identification of a flanking genetic marker.
    Ferrer J; Wasson J; Salkoff L; Permutt MA
    Diabetologia; 1996 Aug; 39(8):891-8. PubMed ID: 8858210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet Amyloid in Patients With Diabetes Due to Exocrine Pancreatic Disorders, Type 2 Diabetes, and Nondiabetic Patients.
    Ueberberg S; Nauck MA; Uhl W; Montemurro C; Tannapfel A; Clark A; Meier JJ
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32271378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal 3-D/2-D human islet and duct imaging in exocrine and endocrine lesion environment: associated pancreas tissue remodeling.
    Chung MH; Chien HJ; Peng SJ; Chou YH; Chiang TC; Chang HP; Lee CY; Chen CC; Jeng YM; Tien YW; Tang SC
    Am J Physiol Endocrinol Metab; 2022 Oct; 323(4):E354-E365. PubMed ID: 35947703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies.
    Ueberberg S; Jütte H; Uhl W; Schmidt W; Nauck M; Montanya E; Tannapfel A; Meier J
    Diabetes Obes Metab; 2016 Dec; 18(12):1253-1262. PubMed ID: 27545110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exocrine pancreatic function in diabetes mellitus.
    Gröger G; Layer P
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):740-6. PubMed ID: 7496861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.